Noticias Institucionales

<p>Scheme of therapeutic concept designed by IRB Barcelona. The protein frataxina binds to peptide shuttle (blue), allowing the protein to cross the blood brain barrier and reach the brain (IRB Barcelona)</p>
14 Mar 2017

IRB Barcelona starts a project with the long-term goal to achieve an injectable frataxin treatment able to reach the brain.

Frataxin is the protein that is reduced in those affected by this rare and degenerative disease, which has no cure.

The patients’ associations Babel Family and ASOGAF in Granada provide the funding for the initial 18 months of this challenge.

<p>Marc Liesa, 2017 IRB Barcelona Alumni of Excellence Award.</p>
28 Feb 2017

Marc Liesa received his PhD in 2008 after completing his doctoral studies in Antonio Zorzano's Complex Metabolic Diseases and Mitochondria Laboratory.

This award recognises the excellence of former IRB Barcelona scientists.

The jury for the prize acknowledges Marc Liesa’s important contributions to mitochondrial biology.

<p>LegoLish-Mot, the second prototype of LEGOLish. Image: Julien Colombelli, Core Facility Manager of the Advanced Digital Microscopy Laboratory at IRB Barcelona.</p>
23 Feb 2017

IRB Barcelona is to participate in the first edition of YoMo Barcelona by giving a Lego fluorescence microscope workshop on March 1.

It is a unique and creative project that brings the latest 3D imaging technology to schools, high schools and universities.

Julien Colombelli, co-inventor of the microscope and Core Facility Manager of the Advanced Digital Microscopy Laboratory, will be coordinating the workshop.

<p>The fundraising campaign called "Future" (#IRBfutur) was launched at the end of 2016 to raise public awareness of the role that biomedical research plays in advancing medicine (L.T. Barone, IRB Barcelona)</p>
21 Feb 2017

The positive public response to the "Futur" fund-raising campaign launched by IRB Barcelona towards the end of 2016 sets the stage for a new "IRB Barcelona Futur PhD Fellowship".

The fellowship will allow a young researcher to join an IRB Barcelona lab to do a 4-year doctoral thesis.

<p>The third edition of the PhD4MD programme is launched today</p>
17 Feb 2017

Research centres of excellence in Barcelona offer PhD fellowships to medical doctors.

Called PhD4MD, the programme allows medical doctors to carry out a three-year doctoral thesis on cancer, rare disease or neurodegenerative conditions.

<p>Marco Milán.</p>
15 Feb 2017

The “Meet Our Scientists” video entitled “Our relative the fly” presents the research performed by Marco Millán on the fruit fly.

He studies the cellular and molecular mechanisms underlying the regulation of tissue growth during normal development, its proper functioning and the formation of a tumour.

<p>Merus N.V. is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics.</p>
9 Feb 2017

The research collaboration will combine Merus’ Biclonics technology platform and unique cell and animal models at the Colorectal Cancer Laboratory led by Eduard Batlle to investigate the stroma.

<p>Antonio Zorzano, group leader of the Complex Metabolic Diseases and Mitochondria Laboratory at IRB Barcelona.</p>
8 Feb 2017

Antonio Zorzano, group leader of the Complex Metabolic Diseases and Mitochondria Laboratory, heads the study.

The Ramón Areces Foundation has granted 120,000 euros for this 3-year project.

 

<p>Salvador Aznar Benitah, Group Leader of the Stem Cell and Cancer Lab at IRB Barcelona.</p>
3 Feb 2017

The Barcelona City Council acknowledges the relevance of his work for metastasis research. 

<p>Aznar Benitah receives the VI "Premio Nacional de Investigación en Cáncer 'Doctores Diz Pintado'" (from left to right) Eugenio Santo, Mª Ángeles Serrano, Salvador Aznar Benitah and Nicolás Rodríguez (USAL)</p>
30 Jan 2017

ICREA researcher and group leader of the Stem Cells and Cancer Laboratory at IRB Barcelona receives an award for his work on cancer.

The prize acknowledges Salvador Aznar Benitah's contributions to transferring knowledge from basic to clinical research.